Blocking anti-IL20Rb monoclonal antibodies could be also of high interest in COPD pathogenesis, since it can neutralize the effect of IL-19, IL-20 and IL-24, these cytokines being induced by CS exposure. Here, IL19 is linked to chronic obstructive pulmonary disease.